Immune response to SARS-CoV-2 in severe disease and long COVID-19

被引:22
|
作者
Sumi, Tomonari [1 ,2 ]
Harada, Kouji [3 ,4 ]
机构
[1] Okayama Univ, Res Inst Interdisciplinary Sci, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan
[2] Okayama Univ, Fac Sci, Dept Chem, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan
[3] Toyohashi Univ Technol, Dept Comp Sci & Engn, Tempaku Cho, Toyohashi, Aichi 4418580, Japan
[4] Toyohashi Univ Technol, Ctr IT Based Educ, Tempaku Cho, Toyohashi, Aichi 4418580, Japan
关键词
DENDRITIC CELLS; T-CELLS; ANTIBODY; VIRUS; INNATE; PERSISTENCE; MECHANISMS; MODEL; ACE2; LIFE;
D O I
10.1016/j.isci.2022.104723
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
COVID-19 is mild to moderate in otherwise healthy individuals but may nonetheless cause life-threatening disease and/or a wide range of persistent symptoms. The general determinant of disease severity is age mainly because the immune response declines in aging patients. Here, we developed a mathematical model of the immune response to SARS-CoV-2 and revealed that typical age-related risk factors such as only a several 10% decrease in innate immune cell activity and inhibition of type-I interferon signaling by autoantibodies drastil ally increased the viral load. It was reported that the numbers of certain dendritic cell subsets remained less than half those in healthy donors even seven months after infection. Hence, the inflammatory response was ongoing. Our model predicted the persistent DC reduction and showed that certain patients with severe and even mild symptoms could not effectively eliminate the virus and could potentially develop long COVID.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Differences in Immune Response to SARS-CoV-2 in mild and severe COVID-19 Disease
    Fuhrmann, Cornelia
    INTERNIST, 2020, 61 (08): : 788 - 788
  • [2] Differences in the Immune Response to SARS-CoV-2 in mild and severe COVID-19-disease
    不详
    PNEUMOLOGE, 2021, 18 (02): : 74 - 74
  • [3] A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia
    Pita-Martinez, Carlos
    Perez-Garcia, Felipe
    Berdices, Ana Virseda
    Martin-Vicente, Maria
    Castilla-Garcia, Lucia
    Fernandez, Irene Hervas
    Ventosa, Victoria Gonzalez
    Munoz-Gomez, Maria Jose
    Cuadros-Gonzalez, Juan
    Bermejo-Martin, Jesus F.
    Resino, Salvador
    Martinez, Isidoro
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 134 : 126 - 132
  • [4] The immune response to SARS-CoV-2 and COVID-19 immunopathology -- Current perspectives
    Boechat, J. L.
    Chora, I.
    Morais, A.
    Delgado, L.
    PULMONOLOGY, 2021, 27 (05): : 423 - 437
  • [5] COVID-19 Gastrointestinal Symptoms and Attenuation of the Immune Response to SARS-CoV-2
    Miller, Jonathan
    Yan, Kelley S.
    GASTROENTEROLOGY, 2021, 160 (07) : 2251 - 2254
  • [6] Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
    Azkur, Ahmet Kursat
    Akdis, Mubeccel
    Azkur, Dilek
    Sokolowska, Milena
    van de Veen, Willem
    Bruggen, Marie-Charlotte
    O'Mahony, Liam
    Gao, Yadong
    Nadeau, Kari
    Akdis, Cezmi A.
    ALLERGY, 2020, 75 (07) : 1564 - 1581
  • [7] Research Response to SARS-CoV-2/COVID-19
    Burger, Charles D. y
    Mikhail, Amanda E.
    Orenstein, Robert
    Ebbert, Jon O.
    Vergidis, Paschalis
    Badley, Andrew D.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (09) : S52 - S55
  • [8] Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
    Olea, Beatriz
    Albert, Eliseo
    Torres, Ignacio
    Amat, Paula
    Remigia, Maria Jose
    Gozalbo-Rovira, Roberto
    Rodriguez-Diaz, Jesus
    Buesa, Javier
    Luisa Blasco, Maria
    Redon, Josep
    Signes-Costa, Jaime
    Navarro, David
    JOURNAL OF CLINICAL VIROLOGY, 2021, 142
  • [9] SARS-CoV-2, COVID-19 and the aging immune system
    Bartleson, Juliet M.
    Radenkovic, Dina
    Covarrubias, Anthony J.
    Furman, David
    Winer, Daniel A.
    Verdin, Eric
    NATURE AGING, 2021, 1 (09): : 769 - 782
  • [10] SARS-CoV-2, COVID-19 and the aging immune system
    Juliet M. Bartleson
    Dina Radenkovic
    Anthony J. Covarrubias
    David Furman
    Daniel A. Winer
    Eric Verdin
    Nature Aging, 2021, 1 : 769 - 782